The effect of interleukin-17 on the course of juvenile idiopathic arthritis

The effect of interleukin-17 on the course of juvenile idiopathic arthritis

Background. Juvenile idiopathic arthritis (JIA) is a heterogeneous group of chronic joint diseases in children who have different course and prognosis, so they continue to be investigated. In the presented part of the study, the content of soluble ІL-17-retseptoru, ІL-1 and γ -interferon in blood se...

Full description

Saved in:

Bibliographic Details
Main Authors:	Oshlyanska, O., I.V. Dzyublyk, N.A. Melanchuk + https://orcid.org/0000-0003-4320-8250
Format:	Article
Language:	English
Published:	V. N. Karazin Kharkiv National University 2024-12-01
Series:	Journal of V. N. Karazin Kharkiv National University: Series Medicine
Subjects:	children juvenile arthritis course interleukin-17 inflammation joints
Online Access:	https://ukrmedsci.com/index.php/visnyk/article/view/88
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pattern of Interleukin-17A and Interleukin-1β in Migraine Patients
by: Fardin Faraji, et al.
Published: (2024-08-01)

Course of uveitis in patients with ankylosing spondylitis during the interleukin 17 inhibitors therapy
by: A. A. Godzenko, et al.
Published: (2023-10-01)

Salivary Levels of Interleukin-17 in Iranian Patients With Systemic Sclerosis
by: Ali Tadayon, et al.
Published: (2024-12-01)

The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?
by: E. L. Nasonov, et al.
Published: (2023-04-01)

New areas of the pharmacotherapy of rheumatic diseases are inhibition of interleukin-6 and interleukin-17
by: Evgeny Lvovich Nasonov
Published: (2013-10-01)

INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS
by: Sh. F. Erdes
Published: (2016-09-01)

Efficacy of interleukin-17 inhibitors in psoriasis patients: a comparative non-randomized study
by: Arfenya E. Karamova, et al.
Published: (2025-06-01)

The Pivotal Role of Interleukin-17 in the Pathogenesis of Systemic Lupus Erythematosus
by: Duaa Sami Segatri, et al.
Published: (2025-06-01)

A Review on Wave Energy Harvesting Technologies
by: Alaaddin Yılmazer, et al.
Published: (2024-12-01)

TH-17 PHENOTYPE OF JUVENILE IDIOPATHIC ARTHRITIS
by: I. Z. Turtsevich1, et al.
Published: (2015-08-01)

The role of interleukin 17 in the pathogenesis of giant cell arteritis: new possibilities for pharmacotherapy
by: E. L. Nasonov, et al.
Published: (2024-12-01)

Clinical values of serum interleukin-17A and interleukin-23 in predicting the occurrence and progression of IgA vasculitis nephritis
by: Peng Li, et al.
Published: (2022-10-01)

Apoio na adoção da Lei Geral de Proteção de Dados Pessoais por meio de anotações semânticas em descrições de serviços Web
by: Dornélio Mori Junior, et al.
Published: (2025-01-01)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
by: Tomasz Kaczyński, et al.
Published: (2019-09-01)

The role of interleukin-17 in neurological disorders
by: Seung Eun Park, et al.
Published: (2025-12-01)

Serum interleukin-17 expression in postmenopausal women and its relation to osteoporosis and risk of fractures
by: Samar G. Soliman, et al.
Published: (2025-01-01)

Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis
by: M. M. Kostik, et al.
Published: (2013-09-01)

Effects of Chinese Medicine on modulating interleukin-17-regulated macrophages in coronary heart disease
by: Qingqing Liu, et al.
Published: (2025-04-01)

Interleukin-17 signaling influences CD8+ T cell immunity and tumor progression according to the IL-17 receptor subunit expression pattern in cancer cells
by: Constanza Rodriguez, et al.
Published: (2023-12-01)

Molecular mechanism of Haikun Shenxi Capsules as adjuvant therapy for diabetic kidney disease through the interleukin-23/interleukin-17 inflammatory axis
by: Zhang An-na, et al.
Published: (2025-06-01)

Successful Treatment of Pediatric Generalized Pustular Psoriasis with Secukinumab
by: Yu K, et al.
Published: (2025-01-01)

Evaluation of Serum Interleukin-17, Transforming Growth Factor-beta Levels in Brucellosis Patients Before and After Treatment
by: Roozbeh Esalatmanesh1, et al.
Published: (2022-12-01)

Understanding the role of immune-mediated inflammatory disease related cytokines interleukin 17 and 23 in pregnancy: A systematic review
by: Aniek Plug, et al.
Published: (2025-06-01)

NEW POSSIBILITIES OF PHARMACOTHERAPY FOR IMMUNOINFLAMMATORY RHEUMATIC DISEASES: A FOCUS ON INHIBITORS OF INTERLEUKIN-17
by: E. L. Nasonov
Published: (2017-03-01)

The Use of Tocilizumab in 40 Patients With Polyarticular Juvenile Idiopathic Arthritis: the Results of a Retrospective Study
by: Mikhail M. Kostik, et al.
Published: (2017-06-01)

Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors
by: Christopher Willy Schwarz, et al.
Published: (2025-08-01)

Therapeutic potential of interleukin-17 neutralization in a novel humanized mouse model of Sjögren’s disease
by: Sulan Yu, et al.
Published: (2024-12-01)

Blood molecular subtypes to guide precision treatment strategies in systemic juvenile idiopathic arthritis
by: In-Woon Baek, et al.
Published: (2025-02-01)

Prognostic impact of serum interleukin-6 and 17 level in patients with bladder cancer: a systematic review and meta-analysis
by: Liang Liu, et al.
Published: (2025-04-01)

Use of the interleukin-17A inhibitor secukinumab in psoriatic arthritis: a subanalysis of the Russian population in the international randomized clinical trials FUTURE 1 and FUTURE 2
by: T. V. Korotaeva, et al.
Published: (2017-04-01)

Serum Interleukin-6, Interleukin-17A, and transforming growth factor beta are raised in systemic sclerosis with interstitial lung disease
by: Anupam Wakhlu, et al.
Published: (2018-01-01)

Interleukin-17 prevents oxidative stress from damaging osteoblast formation by inhibiting autophagic degradation of metallothionein-2
by: Xueyan Ling, et al.
Published: (2024-06-01)

Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways
by: Shuo Gong, et al.
Published: (2025-01-01)

Evaluation of the efficiency and safety of tocilizumab therapy in patients with systemic-onset juvenile idiopathic arthritis: results of a retrospective follow-up
by: M. M. Kostik, et al.
Published: (2018-01-01)

Early juvenile arthritis – results of two-year follow up
by: S O Salugina, et al.
Published: (2009-12-01)

RETRACTED ARTICLE: Interleukin-27 ameliorates coxsackievirus-B3-induced viral myocarditis by inhibiting Th17 cells
by: Hengshan Zhu, et al.
Published: (2015-11-01)

PROSPECTS FOR USING INTERLEUKIN-17 INHIBITORS, A NEW CLASS OF DRUGS FOR TARGETED THERAPY OF PSORIATIC ARTHRITIS
by: T. V. Korotaeva
Published: (2016-07-01)

Administration of the Interleukin-1 Inhibitor Canakinumab in Children with Autoinflammatory Diseases and Systemic Juvenile Arthritis: the Report for Case Series
by: S. O. Salugina, et al.
Published: (2016-02-01)

Spinal astrocyte-derived interleukin-17A promotes pain hypersensitivity in bone cancer mice
by: Huizhu Liu, et al.
Published: (2024-12-01)

Effect of birth and slaughter seasons on Hanwoo carcass characteristics
by: Won-Young Lee, et al.
Published: (2024-09-01)